Evaluation of the Relationship Between Serum Selenium Level and Glycemic Control in Pregnant Patients*
1 other identifier
interventional
220
1 country
1
Brief Summary
Gestational diabetes mellitus (GDM) occurs in approximately 15% of all pregnancies worldwide.GDM can lead to the development of type 2 diabetes mellitus (T2DM) later in a woman's life. Babies of mothers with GDM have a greater risk of developing T2DM and cardiovascular disease than infants of women without GDM. The degree of insulin resistance is directly proportional to the accumulated free radicals. Selenium functions as an active site component of an antioxidant enzyme, glutathione peroxidase, and helps scavenge free radicals. In addition, an experimental study has shown that selenium provides activation by binding to insulin receptors and lowers blood sugar by increasing glucose uptake by cells. According to all this information, we aimed to evaluate the effect of selenium on blood sugar regulation in pregnant patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2023
CompletedFirst Posted
Study publicly available on registry
April 21, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedJune 28, 2023
June 1, 2023
2 months
April 10, 2023
June 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
five day fasting glucose average
five-day fasting glucose average during treatment after one month of treatment
four weeks
five-day first hour postprandial glucose average
five-day first hour postprandial glucose average during treatment after one month of treatment
four weeks
five-day second hour postprandial glucose average
five-day second hour postprandial glucose average during treatment after one month of treatment
four weeks
Study Arms (2)
only given diet therapy
ACTIVE COMPARATORonly diet theraphy
given diet therapy and selenium
EXPERIMENTALdiet theraphy and 200 mcg selenium
Interventions
Selenium functions as an active site component of an antioxidant enzyme, glutathione peroxidase, and helps scavenge free radicals.
Eligibility Criteria
You may qualify if:
- Presence of one or more of the values of fasting blood glucose ≥ 92, 1st hour ≥ 180 and 2nd hour ≥ 153 among pregnant patients for whom we had an oral glucose tolerance test between 24 and 28 weeks of gestation
- single pregnancy
- to 45 years old
You may not qualify if:
- chronic disease (thyroid dysfunction, acute/chronic liver disease, acute/chronic kidney disease, hypertension )
- Patients with a diagnosis of insulin resistance or diabetes
- Those who use drugs other than iron, vitamin D and multivitamin support
- multiple pregnancy
- patients under 18 years old
- Patients over 45 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medipol University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.prof. Ece YİĞİT
Study Record Dates
First Submitted
April 10, 2023
First Posted
April 21, 2023
Study Start
July 1, 2023
Primary Completion
August 30, 2023
Study Completion
August 31, 2023
Last Updated
June 28, 2023
Record last verified: 2023-06